CYBN logo

Cybin Inc. (CYBN)

Profile

Full Name

Cybin Inc.

Ticker

NYSEAmerican: CYBN

Exchange

NYSE American

Sector

Healthcare

Industry

Biotechnology

Country

Canada

IPO

September 13, 2019

Indexes

Not included

Website

https://www.cybin.com

Employees

50

Key Details

Price

$7.56(-1.69%)

Market cap

$174.13M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$4.01(+42.45% YoY)

PE ratio

-

Next earnings date

Aug 8, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $7.56
    CYBN price is $7.56

    30-Day Relative Volume

    0.87
    CYBN 30-day relative volume is 0.87

    Price Performance

    Price Most recent change

    -1.69%
    CYBN price was down -1.69% on Aug 1, 2025

    Price YTD change

    -14.29%
    CYBN price is down -14.29% since January 1st

    Price 1-year change

    -28.18%
    CYBN price is down -28.18% year-on-year

    Price 3-year change

    -67.91%
    CYBN price is down -67.91% over the past 3 years

    Price Range

    Price All-time high

    $128.44
    CYBN price is currently -94.11% below its historical high of $128.44

    Price 3-year low

    $4.81
    CYBN price is currently +57.17% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $174.13M
    CYBN market capitalization is $174.13 million

    Market cap 3-year change

    +69.07%
    CYBN market capitalization is up +69.07% over the past 3 years

    Market cap All-time high

    $1.65B
    CYBN market capitalization is currently -89.47% below its historical high of $1.65 billion

    Market cap sector rank

    50.91%
    CYBN market capitalization is higher than 50.91% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +15.21%
    CYBN shares outstanding is up +15.21% year-on-year

    Shares Outstanding 3-Year Change

    +426.88%
    CYBN shares outstanding is up +426.88% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.95
    CYBN beta is 0.95

    200-day SMA

    $8.59
    CYBN price is currently -11.94% below its 200-day simple moving average

    50-day SMA

    $7.99
    CYBN price is currently -5.34% below its 50-day simple moving average

    RSI

    46.26
    CYBN 14-day relative strength index is 46.26

    Volume

    0.87
    CYBN 30-day relative volume is 0.87

    ATR

    $0.43
    CYBN average true range is $0.43

    10-day Historical Volatility

    50.39%
    CYBN 10-day historical volatility is 50.39%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    -
    CYBN annual revenue value is unknown

    Revenue Analysts estimate

    -
    CYBN annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    -
    CYBN annual revenue 1-year change is unknown

    Revenue Sector rank

    -
    CYBN annual revenue is unknown

    EPS

    EPS

    -$4.01
    CYBN annual earnings per share is -$4.01

    EPS Analysts estimate

    -$4.12
    CYBN annual earnings per share is currently -2.52% lower than the consensus analysts' forecast

    EPS 1-year change

    +42.45%
    CYBN annual earnings per share is up +42.45% year-on-year

    EPS Sector rank

    23.71%
    CYBN annual earnings per share is higher than 23.71% of companies in Healthcare sector

    Profit

    Gross profit

    -
    CYBN annual gross profit value is unknown

    Gross margin

    -
    CYBN annual gross profit margin value is unknown

    Operating profit

    -$102.80M
    CYBN annual operating income is -$102.80 million

    Operating margin

    -
    CYBN annual operating profit margin value is unknown

    Net income

    -$81.25M
    CYBN annual net profit is -$81.25 million

    Net margin

    -
    CYBN annual net profit margin value is unknown

    Expenses

    Total expenses

    $102.80M
    CYBN annual total expenses is $102.80 million

    Operating expenses

    $102.80M
    CYBN annual total operating expenses is $102.80 million

    Cost of goods sold

    -
    CYBN annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $63.36M
    CYBN annual SGA is $63.36 million

    Depreciation and amortization

    $341.10K
    CYBN annual depreciation & amortization is $341.10 thousand

    Interest expense

    -
    CYBN annual interest expense value is unknown

    Income tax

    -
    CYBN annual income tax value is unknown

    EBIT & EBITDA

    EBIT

    -$102.80M
    CYBN annual earnings before interest & taxes is -$102.80 million

    EBITDA

    -$102.45M
    CYBN annual EBITDA is -$102.45 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $180.71M
    CYBN annual total assets is $180.71 million

    Non current assets

    $64.74M
    CYBN annual long term assets is $64.74 million

    Current assets

    $115.97M
    CYBN annual total current assets is $115.97 million

    Cash and cash equivalents

    $94.35M
    CYBN annual cash & cash equivalents is $94.35 million

    Accounts receivable

    $4.11M
    CYBN annual accounts receivable is $4.11 million

    Inventory

    -
    CYBN annual inventory value is unknown

    Liabilities

    Total liabilities

    $14.97M
    CYBN annual total liabilities is $14.97 million

    Long term liabilities

    $0.00
    CYBN annual total long term liabilities is $0.00

    Current liabilities

    $14.97M
    CYBN annual total current liabilities is $14.97 million

    Accounts payable

    $14.97M
    CYBN annual accounts payable is $14.97 million

    Debt

    Total debt

    $0.00
    CYBN annual total debt is $0.00

    Total debt 1-year change

    -100%
    CYBN annual total debt is down -100% year-on-year

    Long term debt

    -
    CYBN annual long term debt value is unknown

    Short term debt

    $0.00
    CYBN annual short term debt is $0.00

    Equity & Capital

    Shareholders equity

    $165.75M
    CYBN annual stockholders equity is $165.75 million

    Book value

    $165.75M
    CYBN annual book value is $165.75 million

    Retained earnings

    -$237.14M
    CYBN annual retained earnings is -$237.14 million

    Working capital

    $101.01M
    CYBN annual working capital is $101.01 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$72.74M
    CYBN annual cash flow from operations is -$72.74 million

    Cash from operations 1-year change

    -42.43%
    CYBN annual cash flow from operations is down -42.43% year-on-year

    Cash from investing

    -$1.41M
    CYBN annual cash flow from investing activities is -$1.41 million

    Cash from investing 1-year change

    -127.52%
    CYBN annual cash flow from investing activities is down -127.52% year-on-year

    Cash from financing

    $14.50M
    CYBN annual cash flow from financing activities is $14.50 million

    Cash from financing 1-year change

    -92.31%
    CYBN annual cash flow from financing activities is down -92.31% year-on-year

    CAPEX

    CAPEX

    -
    CYBN annual capital expenditures value is unknown

    CAPEX 1-year change

    -
    CYBN annual capital expenditures 1-year change is unknown

    Free Cash Flow

    Free cash flow

    -$74.16M
    CYBN annual free cash flow is -$74.16 million

    Free cash flow 1-year change

    -43.71%
    CYBN annual free cash flow is down -43.71% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    CYBN annual gross profit margin value is unknown

    Operating margin

    -
    CYBN annual operating profit margin value is unknown

    Net margin

    -
    CYBN annual net profit margin value is unknown

    ROA & ROE

    ROA

    -44.96%
    CYBN annual return on assets is -44.96%

    ROE

    -49.02%
    CYBN annual return on equity is -49.02%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    CYBN price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    CYBN price to earnings ratio is unknown

    PB Ratio

    PB ratio

    1.05
    CYBN price to book ratio is 1.05

    PB ratio Sector rank

    40.13%
    CYBN price to book ratio is higher than 40.13% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    CYBN price to sales ratio value is unknown

    PS ratio Sector rank

    -
    CYBN price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $79.78M
    CYBN enterprise value is $79.78 million

    Enterprise value Sector rank

    42.09%
    CYBN enterprise value is higher than 42.09% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -0.78
    CYBN EV/EBITDA is -0.78

    EV/EBITDA Sector rank

    52.3%
    CYBN EV/EBITDA is higher than 52.3% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    7.75
    CYBN annual current ratio is 7.75

    Quick ratio

    -
    CYBN annual quick ratio value is unknown

    Leverage

    Debt to equity

    0.00
    CYBN annual debt to equity ratio is 0.00

    Interest coverage ratio

    -
    CYBN annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    CYBN piotroski f-score value is unknown

    Altman Z-Score

    -
    CYBN altman z-score value is unknown

    Analyst ratings

    Recent major analysts updates

    Jul 8, 25 Canaccord Genuity
    Buy
    Mar 13, 25 Guggenheim
    Buy
    Feb 13, 25 HC Wainwright & Co.
    Buy
    Feb 12, 25 Canaccord Genuity
    Buy
    Jan 27, 25 HC Wainwright & Co.
    Buy
    Nov 19, 24 HC Wainwright & Co.
    Buy
    Nov 19, 24 Canaccord Genuity
    Buy
    Nov 18, 24 HC Wainwright & Co.
    Buy
    Nov 14, 24 Canaccord Genuity
    Buy
    Sep 23, 24 Canaccord Genuity
    Buy

    Institutional Ownership

    Screeners with CYBN included

    Growing Shares Outstanding
    Stocks below SMA 200
    Best performing stocks last 3 months
    Canadian stocks
    Healthcare sector
    All stocks
    Biotech Companies
    Ex Dividend dates calendar
    Small cap stocks
    Earnings next week
    • What is the ticker symbol for Cybin Inc.?
    • Does Cybin Inc. pay dividends?
    • What sector is Cybin Inc. in?
    • What industry is Cybin Inc. in?
    • What country is Cybin Inc. based in?
    • When did Cybin Inc. go public?
    • Is Cybin Inc. in the S&P 500?
    • Is Cybin Inc. in the NASDAQ 100?
    • Is Cybin Inc. in the Dow Jones?
    • When was Cybin Inc.'s last earnings report?
    • When does Cybin Inc. report earnings?

    What is the ticker symbol for Cybin Inc.?

    The ticker symbol for Cybin Inc. is NYSEAmerican:CYBN

    Does Cybin Inc. pay dividends?

    No, Cybin Inc. does not pay dividends

    What sector is Cybin Inc. in?

    Cybin Inc. is in the Healthcare sector

    What industry is Cybin Inc. in?

    Cybin Inc. is in the Biotechnology industry

    What country is Cybin Inc. based in?

    Cybin Inc. is headquartered in Canada

    When did Cybin Inc. go public?

    Cybin Inc.'s initial public offering (IPO) was on September 13, 2019

    Is Cybin Inc. in the S&P 500?

    No, Cybin Inc. is not included in the S&P 500 index

    Is Cybin Inc. in the NASDAQ 100?

    No, Cybin Inc. is not included in the NASDAQ 100 index

    Is Cybin Inc. in the Dow Jones?

    No, Cybin Inc. is not included in the Dow Jones index

    When was Cybin Inc.'s last earnings report?

    Cybin Inc.'s most recent earnings report was on June 30, 2025

    When does Cybin Inc. report earnings?

    The next expected earnings date for Cybin Inc. is August 8, 2025
    On this page